文献速递临床微生物质量管理与危急值

市售培养基对头孢地尔肉汤微量稀释药敏试验的影响

The impact of commercially available media on cefiderocol susceptibility testing by broth microdilution method.
PubMed 文献 · J Clin Microbiol · 2025-08-20

该研究重新评估了铁耗竭阳离子调节MH肉汤(ID-CAMHB)的制备与判读,使用四种MHB来源和85株革兰阴性菌进行肉汤微量稀释法检测。延长螯合时间至6小时可使所有培养基铁浓度降至≤0.03 µg/mL,不同来源ID-CAMHB产生可重复但不同的模态MIC值,BD-BBL和BD-Difco与体内疗效预测相关性最好。研究建议使用BD-BBL或BD-Difco制备的ID-CAMHB,并采用 refined 判读指南处理拖尾现象。

要点

  • 延长螯合时间至6小时可使所有MHB来源铁浓度降至≤0.03 µg/mL。
  • 不同来源ID-CAMHB产生可重复但不同的模态MIC值,影响头孢地尔药敏结果。
  • BD-BBL和BD-Difco来源的ID-CAMHB与体内疗效预测相关性最佳。

核心结论

  • 使用肉汤微量稀释法检测头孢地尔药敏时,应考虑培养基来源的影响,推荐使用BD-BBL或BD-Difco制备的ID-CAMHB。

研究设计与样本

  • 研究重新评估了肉汤微量稀释法,检查培养基铁耗竭的螯合时间,并使用四种MHB来源(BD-BBL、BD-Difco、Oxoid、Merck)和85株革兰阴性菌(大肠埃希菌、肺炎克雷伯菌、铜绿假单胞菌、鲍曼不动杆菌)测试重现性,其中63株此前已在体内评估。

主要发现

  • 延长螯合时间至6小时可使所有培养基铁浓度降至≤0.03 µg/mL。
  • 各培养基来源的MIC重现性高,因菌种而异,93.3%-99.0%的MIC值在模态MIC值的一个稀释度内。
  • 不同来源ID-CAMHB产生可重复但不同的模态MIC值。
  • BD-BBL和BD-Difco来源的ID-CAMHB之间,96.5%的菌株模态MIC值在一个稀释度内。
  • 这两种培养基产生的MIC值对体内疗效的预测性最好。

关键数值与推荐

  • 6小时螯合和针对拖尾的 refined 判读指南已纳入临床和实验室标准协会M100文件。
  • 推荐使用BD-BBL或BD-Difco制备的ID-CAMHB进行头孢地尔肉汤微量稀释药敏试验。

临床怎么用

  • 检验科在进行头孢地尔肉汤微量稀释药敏试验时,应关注MHB培养基来源,优先选用BD-BBL或BD-Difco制备的ID-CAMHB。
  • 制备ID-CAMHB时螯合时间应延长至6小时,并遵循 refined 判读指南处理拖尾现象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The reference method for determining cefiderocol MIC is broth microdilution (BMD) using iron-depleted cation-adjusted Mueller-Hinton broth (ID-CAMHB). However, laboratories have reported variable MIC findings and difficulties in determining MIC endpoints. To investigate this, the BMD method was re-evaluated by examining the chelation time for iron depletion of the media and by testing reproducibility using four MHB sources (BD-BBL, BD-Difco, Oxoid, and Merck) and 85 Gram-negative isolates (Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii), of which 63 were previously evaluated in vivo. Extending chelation time to 6 h provided optimal iron reduction to ≤0.03 µg/mL for all media. MIC reproducibility was high for each medium source and varied by species (93.3%-99.0% of MIC values within one dilution of modal MIC values); however, different sources of ID-CAMHB produced (reproducible) different modal MIC values for isolates. ID-CAMHB from BD-BBL and BD-Difco showed the best correlation with 96.5% of isolates showing modal MIC values within one dilution between media. MIC values generated with these two media were the most predictive of efficacy in vivo. When trailing was observed, it was seen across all media, and refined reading guidelines were applied to enhance reproducibility of determining the MIC endpoint. The 6-h chelation and the refined reading guidelines for trailing are now incorporated into the Clinical and Laboratory Standards Institute M100 document. When using the BMD method to determine cefiderocol susceptibility, the impact of media should be considered, and based on these results, ID-CAMHB prepared with BD-BBL or BD-Difco is recommended.IMPORTANCEThe reference antibiotic susceptibility testing method for cefiderocol is the broth microdilution method approved by the Clinical and Laboratory Standards Institute in 2016, using iron-depleted cation-adjusted Mueller-Hinton broth. A few manual devices have come to the market replicating this method, but inconsistent results with these devices have been reported. The current study identified the source of Mueller-Hinton broth as a variable in cefiderocol MIC determinations and provides detailed description of the preparation of iron-depleted cation-adjusted Mueller-Hinton broth, and revised reading guidance to improve reproducibility of cefiderocol MIC determinations for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. The recommendations made in this study should enhance the reproducibility of cefiderocol broth microdilution susceptibility testing.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. DeJonge BL, Slover C, Nguyen ST, et al. The impact of commercially available media on cefiderocol susceptibility testing by broth microdilution method. J Clin Microbiol. 2025. PMID: 40833077. doi:10.1128/jcm.00471-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。